Molecular orchestration of differentiation and function of regulatory T cells

Genes and Development

Volumn 23, Issue 11, 2009, Pages 1270-1282

  Lu, Li Fan ^a   Rudensky, Alexander ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Differentiation; T lymphocytes; Tolerance; Transcriptional regulation

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2 RECEPTOR ALPHA; MICRORNA; NEUROPILIN 1; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR;

CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SECRETION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; CD4+ T LYMPHOCYTE; CYTOLOGY; IMMUNOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICRORNAS; T-LYMPHOCYTES, REGULATORY;

EID: 66149190937     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1791009     Document Type: Review

References (137)

1. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, Ziegler SF, Roncarolo MG, Levings MK. 2005. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 115: 3276-3284. (Pubitemid 41567592)
2. Apostolou I, Sarukhan A, Klein L, von Boehmer H. 2002. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 3: 756-763.
3. Asano M, Toda M, Sakaguchi N, Sakaguchi S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184: 387-396. (Pubitemid 26324092)
4. Bachmann MF, Kohler G, Ecabert B, Mak TW, Kopf M. 1999. Cutting edge: Lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol 163: 1128-1131. (Pubitemid 29352726)
5. + conventional T cells. Eur J Immunol 37: 2378-2389.
6. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297. (Pubitemid 38167318)
7. + T regulatory cell development during the neonatal period. J Exp Med 201: 769-777.
8. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21. (Pubitemid 32044513)
9. Bettelli E, Dastrange M, Oukka M. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci 102: 5138-5143. (Pubitemid 40503752)
10. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
11. Bonomo A, Kehn PJ, Payer E, Rizzo L, Cheever AW, Shevach EM. 1995. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J Immunol 154: 6602-6611.
12. Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, et al. 2007. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204: 1303-1310. (Pubitemid 46919868)
13. + Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
14. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W. 2004. Neuropilin-1: A surface marker of regulatory T cells. Eur J Immunol 34: 623-630. (Pubitemid 39255909)
15. + memory T cells. J Immunol 171: 5853-5864.
16. + regulatory T cells. J Immunol 178: 280-290.
17. Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio CW, Vegoe AL, Hsieh CS, Jenkins MK, Farrar MA. 2008. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28: 112-121.
18. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106: R75-R81. doi: 10.1172/JCI11679. (Pubitemid 32038594)
19. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
20. Chen Z, Benoist C, Mathis D. 2005. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci 102: 14735-14740. (Pubitemid 41457125)
21. Chong MM, Rasmussen JP, Rudensky AY, Littman DR. 2008. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205: 2005-2017.
22. Cobaleda C, Jochum W, Busslinger M. 2007. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449: 473-477. (Pubitemid 47509547)
23. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J, Wilson CB, Brockdorff N, Fisher AG, Smale ST, et al. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 201: 1367-1373. (Pubitemid 40664081)
24. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, et al. 2006. A role for Dicer in immune regulation. J Exp Med 203: 2519-2527. (Pubitemid 44664621)
25. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569. (Pubitemid 350190247)
26. + T regulatory cells. J Immunol 178: 4022-4026.
27. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265. (Pubitemid 46919862)
28. Fehervari Z, Sakaguchi S. 2004. CD4+ Tregs and immune control. J Clin Invest 114: 1209-1217.
29. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5: e38. doi: 10.1371/journal.pbio.0050038.
30. + regulatory T cells. Nat Immunol 4: 330-336.
31. Fontenot JD, Dooley JL, Farr AG, Rudensky AY. 2005a. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 202: 901-906. (Pubitemid 41396890)
32. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. 2005b. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6: 1142-1151. (Pubitemid 41541792)
33. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. 2005c. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
34. + regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 16: 421-434.
35. + regulatory T cell function. J Exp Med 196: 851-857.
36. Gambineri E, Torgerson TR, Ochs HD. 2003. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15: 430-435. (Pubitemid 36774255)
37. + suppressor T cells in vivo. Nat Immunol 3: 33-41.
38. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci 103: 6659-6664.
39. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, Rudensky AY. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775. (Pubitemid 46279714)
40. Godfrey VL, Rouse BT, Wilkinson JE. 1994. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol 145: 281-286. (Pubitemid 24245827)
41. Gondek DC, Devries V, Nowak EC, Lu LF, Bennett KA, Scott ZA, Noelle RJ. 2008. Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells. J Immunol 181: 4752-4760.
42. Grant C, Oh U, Fugo K, Takenouchi N, Griffith C, Yao K, Newhook TE, Ratner L, Jacobson S. 2006. Foxp3 represses retroviral transcription by targeting both NF-κB and CREB pathways. PLoS Pathog 2: e33. doi: 10.1371/journal.ppat.0020033.
43. Gupta S, Manicassamy S, Vasu C, Kumar A, Shang W, Sun Z. 2008. Differential requirement of PKC-θ in the development and function of natural regulatory T cells. Mol Immunol 46: 213-224.
44. + cells. J Exp Med 205: 565-574.
45. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199: 1479-1489.
46. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786-800. (Pubitemid 350110546)
47. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
48. + Treg. Eur J Immunol 38: 912-915.
49. Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY. 2006. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol 7: 401-410.
50. + T helper cells. Cell 126: 1121-1133.
51. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2: 301-306.
52. Josefowicz SZ, Wilson CB, Rudensky AY. 2009. TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase I. J Immunol (in press).
53. + T regulatory cells. Nat Immunol 4: 337-342.
54. Kim HP, Leonard WJ. 2007. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: A role for DNA methylation. J Exp Med 204: 1543-1551. (Pubitemid 47048022)
55. Kim JM, Rasmussen JP, Rudensky AY. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197. (Pubitemid 46152650)
56. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. 2006. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 177: 6780-6786. (Pubitemid 44715042)
57. + T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci 106: 1903-1908.
58. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, Jensen K, Cobb BS, Merkenschlager M, Rajewsky N, et al. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874.
59. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78: 399-408. (Pubitemid 24250805)
60. + regulatory T cells induces a scurfy-like disease. J Exp Med 204: 57-63.
61. Lee SM, Gao B, Fang D. 2008. FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1. Blood 111: 3599-3606.
62. Lenschow DJ, Walunas TL, Bluestone JA. 1996. CD28/B7 system of T cell costimulation. Annu Rev Immunol 14: 233-258. (Pubitemid 26130184)
63. Li B, Greene MI. 2007. FOXP3 actively represses transcription by recruiting the HAT/HDAC complex. Cell Cycle 6: 1432-1436.
64. Li B, Samanta A, Song X, Iacono KT, Bembas K, Tao R, Basu S, Riley JL, Hancock WW, Shen Y, et al. 2007. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci 104: 4571-4576. (Pubitemid 47186266)
65. LinW, Haribhai D, Relland LM, Truong N, Carlson MR, Williams CB, Chatila TA. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 8: 359-368. (Pubitemid 46745411)
66. Lio CW, Hsieh CS. 2008. A two-step process for thymic regulatory T cell development. Immunity 28: 100-111.
67. Liston A, Farr AG, Chen Z, Benoist C, Mathis D, Manley NR, Rudensky AY. 2007. Lack of Foxp3 function and expression in the thymic epithelium. J Exp Med 204: 475-480. (Pubitemid 46457071)
68. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY. 2008. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205: 1993-2004.
69. + regulatory T cells. Nat Immunol 9: 632-640.
70. Lohoff M, Mittrucker HW, Prechtl S, Bischof S, Sommer F, Kock S, Ferrick DA, Duncan GS, Gessner A, Mak TW. 2002. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci 99: 11808-11812. (Pubitemid 34994480)
71. Lopes JE, Torgerson TR, Schubert LA, Anover SD, Ocheltree EL, Ochs HD, Ziegler SF. 2006. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 177: 3133-3142. (Pubitemid 44277831)
72. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, Scott ZA, Coyle AJ, Reed JL, Van Snick J, et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002. (Pubitemid 44330250)
73. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, Loeb GB, Lee H, Yoshimura A, Rajewsky K, et al. 2009. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91.
74. Malek TR. 2008. The biology of interleukin-2. Annu Rev Immunol 26: 453-479.
75. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17: 167-178.
76. Malek TR, Yu A, Zhu L, Matsutani T, Adeegbe D, Bayer AL. 2008. IL-2 family of cytokines in T regulatory cell development and homeostasis. J Clin Immunol 28: 635-639.
77. Mantel PY, Ouaked N, Ruckert B, Karagiannidis C, Welz R, Blaser K, Schmidt-Weber CB. 2006. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176: 3593-3602. (Pubitemid 43364007)
78. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935. (Pubitemid 46309829)
79. + immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
80. + T regulatory cells in humans. Hum Immunol 66: 13-20.
81. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. 2005. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202: 261-269. (Pubitemid 41043822)
82. Nishizuka Y, Sakakura T. 1969. Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166: 753-755.
83. O'Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ, Miska EA, Tarakhovsky A. 2007. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes & Dev 21: 1999-2004. (Pubitemid 47267286)
84. Ohki H, Martin C, Corbel C, Coltey M, Le Douarin NM. 1987. Tolerance induced by thymic epithelial grafts in birds. Science 237: 1032-1035. (Pubitemid 17124674)
85. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188: 1883-1894.
86. Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, Nomura T, Miyachi Y, Tsukada T, Sakaguchi S. 2007. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446: 685-689. (Pubitemid 46606883)
87. Ou-Yang HF, Zhang HW, Wu CG, Zhang P, Zhang J, Li JC, Hou LH, He F, Ti XY, Song LQ, et al. 2009. Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms. Mol Cell Biochem 320: 109-114.
88. Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ, Rakowski C, Chatterjee C, Lieberman PM, Lane WS, et al. 2004. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 24: 10826-10834. (Pubitemid 39603138)
89. + regulatory T cells. J Immunol 177: 6598-6602.
90. Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J. 2008. DNA methylation controls Foxp3 gene expression. Eur J Immunol 38: 1654-1663.
91. + regulatory cells that control intestinal inflammation. J Exp Med 192: 295-302.
92. + regulatory T cells abrogates their function in vivo. J Immunol 177: 4376-4383.
93. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. 2002. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 195: 1003-1012. (Pubitemid 34412002)
94. Ronchetti S, Nocentini G, Riccardi C, Pandolfi PP. 2002. Role of GITR in activation response of T lymphocytes. Blood 100: 350-352.
95. Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G, Ayroldi E, Riccardi C. 2004. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34: 613-622. (Pubitemid 39255908)
96. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castell L, Ye X, Treuting P, Siewe L, Roers A, Henderson WRJ, et al. 2008. IL-10 produced by regulatory T cells contributes to their suppressor function by limiting inflammation at environmental interfaces. Immunity 28: 546-558.
97. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
98. Sakaguchi S, Takahashi T, Nishizuka Y. 1982. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 156: 1565-1576.
99. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
100. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
101. Samon JB, Champhekar A, Minter LM, Telfer JC, Miele L, Fauq A, Das P, Golde TE, Osborne BA. 2008. Notch1 and TGFβ1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 112: 1813-1821.
102. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. 2008. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28: 402-413.
103. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O'Connor E, et al. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci 105: 7797-7802.
104. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc Natl Acad Sci 101: 4566-4571.
105. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276: 37672-37679. (Pubitemid 37384195)
106. Shevach EM. 2000. Regulatory T cells in autoimmmunity. Annu Rev Immunol 18: 423-449. (Pubitemid 30365387)
107. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3: 135-142.
108. Starr TK, Jameson SC, Hogquist KA. 2003. Positive and negative selection of T cells. Annu Rev Immunol 21: 139-176. (Pubitemid 37174529)
109. + T cells. J Immunol 173: 5008-5020.
110. + natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 18: 1197-1209.
111. + T cells and dendritic cells in vivo. J Exp Med 203: 505-511.
112. Tai X, Cowan M, Feigenbaum L, Singer A. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6: 152-162. (Pubitemid 40268196)
113. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192: 303-310.
114. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7: 83-92. (Pubitemid 41823872)
115. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
116. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9: 194-202.
117. Trombetta ES, Mellman I. 2005. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23: 975-1028. (Pubitemid 40563191)
118. + regulatory T cell development. J Immunol 181: 3285-3290.
119. - T cells. J Clin Invest 112: 1437-1443.
120. Wan YY, Flavell RA. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci 102: 5126-5131. (Pubitemid 40503750)
121. Wan YY, Flavell RA. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770. (Pubitemid 46279706)
122. + T cells. Eur J Immunol 37: 129-138.
123. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20. (Pubitemid 32044512)
124. Williams LM, Rudensky AY. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8: 277-284. (Pubitemid 46745377)
125. + regulatory T cell function. Science 322: 271-275.
126. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387. (Pubitemid 44092960)
127. Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford WT, Laurence A, Robinson GW, Shevach EM, Moriggl R, et al. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109: 4368-4375. (Pubitemid 46743405)
128. Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, Tom I, Ivelja S, Refino CJ, Clark H, et al. 2009. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 10: 48-57.
129. - cells to develop suppressive activity: The role of IL-2, TGF-β, and IL-10. J Immunol 172: 5213-5221.
130. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940. (Pubitemid 46309837)
131. Zheng Y, Chaudhry A, Kas A, Deroos P, Kim JM, Chu TT, Corcoran L, Treuting P, Klein U, Rudensky AY. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458: 351-356.
132. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, et al. 2008. TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγt function. Nature 453: 236-240.
133. Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA. 2008. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205: 1983-1991.
134. Ziegler SF. 2006. FOXP3: Of mice and men. Annu Rev Immunol 24: 209-226.
135. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.
136. Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, Zheng P. 2007a. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 117: 3765-3773. (Pubitemid 350224087)
137. Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, Liu Y, Wang Y, Liu X, Chan MW, et al. 2007b. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 129: 1275-1286. (Pubitemid 46970708)